| Name | Erenumab |
|---|
| Description | Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |